New York
LondonBeijing
Glioblastoma and New Therapeutic Drugs and Approaches

Glioblastoma and New Therapeutic Drugs and Approaches

Athanasios Alexiou (Novel Global Community Education Foundation, Australia), Md. Habibur Rahman (Southeast University, Bangladesh), Muhasina K.M. (JSS College of Pharmacy, India), Chenmala Karthika (JSS College of Pharmacy, India), and Priti Tagde (Amity Institute Pharmacy, India)
Release Date: December, 2025|Copyright: © 2026 |Pages: 452
DOI: 10.4018/979-8-3373-2695-5
ISBN13: 9798337326955|ISBN13 Softcover: 9798337326962|EISBN13: 9798337326979
Access Full-Text Recommend This Book to Your Library
Softcover:
Forthcoming
$190.00
Benefits & Incentives
TOTAL SAVINGS: $190.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Available through Copyright Clearance Center (CCC)
Softcover:
Forthcoming
$190.00
Benefits & Incentives
TOTAL SAVINGS: $190.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Available through Copyright Clearance Center (CCC)
E-Book:
Available
$220.00
Benefits & Incentives
TOTAL SAVINGS: $220.00
Benefits
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • PDF download
  • Available through Copyright Clearance Center (CCC)
E-Book:
Available
$220.00
Benefits & Incentives
TOTAL SAVINGS: $220.00
Benefits
  • Immediate access after purchase
  • No DRM
  • PDF download
  • Receive a 10% Discount on eBooks
  • Available through Copyright Clearance Center (CCC)
Hardcover:
Forthcoming
$230.00
Benefits & Incentives
TOTAL SAVINGS: $230.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Available through Copyright Clearance Center (CCC)
Hardcover:
Forthcoming
$230.00
Benefits & Incentives
TOTAL SAVINGS: $230.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Available through Copyright Clearance Center (CCC)
Hardcover +
E-Book:
Forthcoming
$275.00
Benefits & Incentives
TOTAL SAVINGS: $275.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Multi-user license (no added fee)
  • Immediate access after purchase
  • No DRM
  • PDF download
  • Available through Copyright Clearance Center (CCC)
Hardcover +
E-Book:
Forthcoming
$275.00
Benefits & Incentives
TOTAL SAVINGS: $275.00
Benefits
  • Printed-On-Demand (POD)
  • Usually ships one day from order
  • Immediate access after purchase
  • No DRM
  • PDF download
  • Available through Copyright Clearance Center (CCC)
Article Processing Charge:
$2,250.00
Benefits & Incentives
TOTAL SAVINGS: $2,250.00
Benefits
  • Available through Copyright Clearance Center (CCC)
Description & Coverage
Description:

Glioblastoma is the most aggressive and lethal form of primary brain tumor in adults, characterized by rapid growth, high invasiveness, and resistance to conventional therapies. Current treatment options offer limited survival benefits. However, recent advancements in molecular biology, genomics, and drug delivery systems pave the way for more effective, targeted therapeutic strategies. Emerging approaches include immunotherapy, gene editing, and personalized medicine. Novel drug candidates and repurposed agents are explored in clinical trials, overcoming the blood-brain barrier and targeting specific mutations driving glioblastoma progression. These evolving therapies may improve outcomes and transform the future landscape of glioblastoma treatment.

Glioblastoma and New Therapeutic Drugs and Approaches explores glioblastoma and new therapeutic drugs under development. It examines innovative treatment modalities, drug delivery regimens, and therapeutic strategies to address glioblastoma care. This book covers topics such as nanomaterials, chemistry, and medical diagnosis, and is a useful resource for medical and healthcare professionals, engineers, drug developers, oncologists, academicians, researchers, and scientists.

Coverage:

The many academic areas covered in this publication include, but are not limited to:

  • Carbon Nanoparticles
  • Chemistry
  • Chemotherapy
  • Clinical Science
  • Drug Delivery and Development
  • Glioblastoma
  • Medical Diagnosis
  • Medical Technology
  • Medical Therapeutics
  • Medical Treatment and Care
  • Nanomaterials
  • Oncology
Download OnDemand Chapters Banner
Table of Contents
Search this Book:
Reset
Editor/Author Biographies
Dr. Athanasios Alexiou has a BSc in Applied Mathematics from the National and Kapodistrian University of Athens, a Ph.D. in Bioinformatics Algorithms and Mathematical Modeling in Biology, and a two-year Postdoc Research Fellowship in Neuroinformatics Applications from the Ionian University. He is the Head of Research & Education at Funogen Research Company in Greece and AFNP Med Company in Austria, an Adjunct Professor at the University Centre for Research & Development at Chandigarh University in India, and the Department of Science and Engineering at the Novel Global Community Education Foundation (an educational platform registered in Australia). He also collaborates with international research teams (including Yerevan State University, King Abdulaziz University, the University of Sharjah and Damanhour University). Dr. Alexiou's area of research is Cross-Field, with a special focus on Computational Biomedicine. Also, it focuses on developing novel mathematical models and algorithms in neurodegenerative diseases, prognostic Bayesian tools for Alzheimer's disease and Neurodegenerative disorders, sustainable agriculture, nanotoxicity in human health, AI and ML methods, identifying molecular mechanisms of infectious diseases, cancer biomarkers, and the ethical implications of scientific research. He serves as an Associate Editor in highly reputed journals like the Frontiers in Genetics and Pharmacology in the Section of ELSI, the Frontiers in Neuroscience and Psychology Journals, as a Section Editor in the Current Alzheimer Research Bentham Science journal, etc.; he is the author of more than 250 peer-reviewed articles/chapters/books in high impact publications and 5 filled patents; he is the editor of several books in known publishing houses; he has delivered many talks and presentations in international conferences and workshops; he participates in several international funded programs; he serves as a Scientific and Program Committee Member in several conferences and as a Reviewer/Member of the Editorial Board of international journals; he is supervising from diploma to Ph.D. theses and internships' programs; he has over 20 years of mentoring and educational experience. The 33rd Marquis Who's Who International Edition, 2016, includes Athanasios' biography. Dr. Alexiou is a Fellow of the International Institute of Biomedical Science and is highly ranked in the Computational Biomedicine field.
Dr. Md. Habibur Rahman , RPh, is a registered pharmacist in Bangladesh and a member of the Novel Global Community Education Foundation (Australia). He earned his Ph.D. in Medical Science from Yonsei University, South Korea, and has worked with several leading pharmaceutical organizations. His research primarily focuses on neuroscience, exploring the molecular mechanisms of clinical dementia with emphasis on biomarker discovery and targeted diagnostics. Recognized among the world's top 2% of scientists (Stanford University ranking), he is also an expert in molecular biology, oxidative stress, and neuroinflammation. Dr. Rahman is adept in advanced molecular and cell biology, animal models, and data analysis, and has mentored international students. He currently serves as Faculty at the Novel Global Community Educational Foundation and Director of the IM Group of Researchers. His achievements include the Hae Rang Best Young Scientist Award and the International Excellence Researcher Award.
Dr. Muhasina K.M. is a distinguished researcher in pharmaceutical sciences, specializing in cancer biology, herbal formulations, and multidrug-resistant cancers. She earned her PhD from JSS College of Pharmacy, Ooty as an AICTE Doctoral fellow, focusing on analytical and biological markers for anticancer herbal formulations. Her research explores phytochemicals’ molecular mechanisms in targeting triple-negative breast cancer and the role of gut microbiota in disease progression. With expertise in advanced analytical techniques, she has authored numerous high-impact publications and secured multiple patents on herbal drug formulations and AI-based pharmaceutical technologies. Recognized with prestigious awards, she continues to advance cancer therapeutics by developing novel plant-based interventions. Beyond her publications, Dr. Muhasina has secured multiple patents on herbal drug formulations and AI-based pharmaceutical technologies. She has been recognized with prestigious awards, including the Best Research Scholar Award and Late SH. Bhola Nath Nikhra Memorial Young Researcher Award. Her research contributions have been widely acknowledged at national and international conferences, where she has delivered award-winning oral presentations. Dr. Muhasina’s career aspiration is to advance cancer therapeutics by identifying novel phytochemicals and herbal formulations to counteract multidrug resistance and metastasis. She aims to bridge pharmaceutical sciences with translational medicine, contributing to developing effective, plant-based therapeutic interventions for cancer and neurological disorders.
Dr. Chenmala Karthika is a postdoctoral fellow at the National Institute of Health, USA. She completed her PhD from JSS College of Pharmacy, Ooty. She worked as an ICMR-senior research fellow during her PhD tenure and had published around 35 national and International paper. For the past 5 years, she has been researching cancer and its therapeutic approaches and had some interest in COVID-19 and neurodegenerative disorders.
Dr. Priti Tagde , M. Pharm, PhD, is an accomplished academician, researcher, and administrator in the field of pharmaceutical sciences. She is currently serving as Project Coordinator at the Madhya Pradesh State Price Monitoring Unit, Office of Food & Drugs Administration, M.P. With over a decade of teaching and research experience, she has held positions as Professor, Associate Professor, and Assistant Professor at reputed institutes. Her research primarily focuses on nanomedicine and innovative drug delivery systems, including lipid-based nanocarriers for breast cancer treatment. Dr. Tagde has authored books, published numerous research papers in international journals, and holds an Australian patent. She has been invited as a keynote speaker, resource person, and chief guest at national and international forums. Recognized globally, she has received honors such as the Pharma Ratan Young Achiever Award and inclusion among the 100 Most Impactful Healthcare Leaders. She also leads PRISAL, an international NGO fostering pharmaceutical education and research.
Archiving
All IGI Global Scientific Publishing content is archived via the CLOCKSS and LOCKSS initiative. Additionally, all IGI Global Scientific Publishing published content is available in the IGI Global Scientific Publishing InfoSci® platform.